Contact Dermatitis Clinical Trial
Official title:
Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
The purpose of this study is to evaluate the diagnostic performance and safety of ascending doses of mercury, aluminum and palladium metal allergens proposed for inclusion in a metal allergen panel. Optimal dose will be selected based on the lowest dose of each allergen eliciting a positive response in 70-90% of subjects tested.
This is a single-center, double-blind, randomized study to compare the diagnostic performance (primary) and safety (secondary) of ascending doses of mercury, aluminum and palladium in 20 adult subjects who have a clinical history of contact dermatitis and have had a past positive patch test to one of the allergens on this study. Investigators and subjects will be blinded to the exact location of each dose within the allergen panel but will not be blinded to the allergen being tested, nor the range of allergen doses within each panel. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00371163 -
Molecular and Cellular Characterization of Spongiotic Dermatitis
|
N/A | |
| Not yet recruiting |
NCT04853823 -
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
|
Phase 1 | |
| Recruiting |
NCT06387472 -
DermAI to Evaluate Human Factor of Testing
|
N/A | |
| Completed |
NCT02700373 -
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03089775 -
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis
|
Phase 1 | |
| Completed |
NCT04438135 -
Children With Aluminium Contact Allergy: Cutaneous Exposure Study
|
N/A | |
| Recruiting |
NCT06189144 -
Testing an Intervention in Irritative Contact Dermatitis
|
N/A | |
| Completed |
NCT04921163 -
Children With Aluminium Contact Allergy: Oral Exposure Study
|
N/A | |
| Not yet recruiting |
NCT02026700 -
Bariederm Cream in Chronic Contact Dermatitis
|
N/A | |
| Completed |
NCT02028182 -
Clinical Evaluation of Lyral® Dose Response Study
|
Phase 2 | |
| Completed |
NCT00824889 -
Exploratory Study of Natural Killer Cells in Human Skin
|
N/A | |
| Completed |
NCT00646867 -
Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
|
N/A | |
| Withdrawn |
NCT01518348 -
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
|
Phase 3 | |
| Recruiting |
NCT03705182 -
Prevention of Dermatitis in Epoxy Exposed Workers
|
N/A | |
| Terminated |
NCT03198390 -
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
|
||
| Completed |
NCT00614289 -
Novel Topical Treatment of Hand Dermatitis (Eczema)
|
Phase 1 | |
| Recruiting |
NCT06331390 -
Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis
|
N/A | |
| Completed |
NCT00640250 -
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
|
Phase 2 | |
| Completed |
NCT00640614 -
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
|
Phase 3 | |
| Recruiting |
NCT06177314 -
Molecular Diagnosis of Allergic Contact Dermatitis
|